APA (7th ed.) Citation

Phong Lu, Erica R. Vander Mause, Katherine E. Redd Bowman, Sarah M. Brown, Lisa Ahne, & Carol S. Lim. (2019). Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53. BMC.

Chicago Style (17th ed.) Citation

Phong Lu, Erica R. Vander Mause, Katherine E. Redd Bowman, Sarah M. Brown, Lisa Ahne, and Carol S. Lim. Mitochondrially Targeted P53 or DBD Subdomain Is Superior to Wild Type P53 in Ovarian Cancer Cells Even with Strong Dominant Negative Mutant P53. BMC, 2019.

MLA (9th ed.) Citation

Phong Lu, et al. Mitochondrially Targeted P53 or DBD Subdomain Is Superior to Wild Type P53 in Ovarian Cancer Cells Even with Strong Dominant Negative Mutant P53. BMC, 2019.